JPS5382771A - Methoxybenzamide derivative - Google Patents

Methoxybenzamide derivative

Info

Publication number
JPS5382771A
JPS5382771A JP15630677A JP15630677A JPS5382771A JP S5382771 A JPS5382771 A JP S5382771A JP 15630677 A JP15630677 A JP 15630677A JP 15630677 A JP15630677 A JP 15630677A JP S5382771 A JPS5382771 A JP S5382771A
Authority
JP
Japan
Prior art keywords
methoxybenzamide
derivative
methoxybenzamide derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15630677A
Other languages
Japanese (ja)
Inventor
Pieeru Eritsuku Jiyan
Najieeru Anri
Mitsushieru Rezon Berunaaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7639033A external-priority patent/FR2375167A1/en
Priority claimed from FR7639034A external-priority patent/FR2378520A1/en
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of JPS5382771A publication Critical patent/JPS5382771A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/807Ketones containing a keto group bound to a six-membered aromatic ring containing halogen all halogen atoms bound to the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP15630677A 1976-12-24 1977-12-23 Methoxybenzamide derivative Pending JPS5382771A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7639033A FR2375167A1 (en) 1976-12-24 1976-12-24 N-1-enzyl-2-pyrrolidinyl-methyl 2-methoxy-benzamide derivs. - esp. the 5-sulphamoyl-benzamide cpds., are psychotropics and neuroleptics
FR7639034A FR2378520A1 (en) 1976-12-24 1976-12-24 N-1-enzyl-2-pyrrolidinyl-methyl 2-methoxy-benzamide derivs. - esp. the 5-sulphamoyl-benzamide cpds., are psychotropics and neuroleptics

Publications (1)

Publication Number Publication Date
JPS5382771A true JPS5382771A (en) 1978-07-21

Family

ID=26219761

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15630677A Pending JPS5382771A (en) 1976-12-24 1977-12-23 Methoxybenzamide derivative

Country Status (14)

Country Link
JP (1) JPS5382771A (en)
AU (1) AU3192177A (en)
DE (1) DE2757406A1 (en)
DK (1) DK575877A (en)
ES (1) ES465366A2 (en)
FI (1) FI773911A (en)
GB (1) GB1556566A (en)
GR (1) GR66082B (en)
IL (1) IL53680A0 (en)
LU (1) LU78773A1 (en)
NL (1) NL7714301A (en)
NO (1) NO774402L (en)
NZ (1) NZ186075A (en)
SE (1) SE7714659L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3005722A1 (en) * 1980-02-15 1981-08-20 Bayer Ag, 5090 Leverkusen TRIFLUORMETHYLBENE CYL ESTER, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF IN PEST CONTROL
CA1157884A (en) * 1980-04-16 1983-11-29 Byron R. Cotter Process for the preparation of trifluoromethylbenzoyl halides

Also Published As

Publication number Publication date
DK575877A (en) 1978-06-25
GB1556566A (en) 1979-11-28
NO774402L (en) 1978-06-27
ES465366A2 (en) 1978-09-16
LU78773A1 (en) 1979-07-20
FI773911A (en) 1978-06-25
GR66082B (en) 1981-01-15
DE2757406A1 (en) 1978-06-29
IL53680A0 (en) 1978-03-10
SE7714659L (en) 1978-06-25
AU3192177A (en) 1979-06-28
NL7714301A (en) 1978-06-27
NZ186075A (en) 1979-11-01

Similar Documents

Publication Publication Date Title
JPS5337696A (en) Hexahydrocantinonee6 derivative
IL52002A0 (en) M-phenoxybenzamide derivatives
GB1541547A (en) 4-phenoxymethylpiperidine derivatives
JPS52133928A (en) Nnphosphonomethylglycine derivative
GB1521020A (en) 4-hydrox-aporphine derivatives
CY1269A (en) Morphanthridine derivative
GB1543124A (en) 2-iminothiazolidine derivatives
HK9585A (en) Nogarol derivatives
PT66360B (en) Nicotinoylaminotriazine derivatives
PH12671A (en) Imidaisoquinoline derivative
PH13715A (en) Napethyl derivative
GB1553759A (en) Tetrahyddropyridine derivatives
JPS52105138A (en) Novellphenyll22aminoethanol derivatives
JPS52116461A (en) Dibenzothiphene derivative
JPS52133988A (en) Substituted pyrandione derivative
GB1549755A (en) N-4-halobutyryl derivatives
GB1523198A (en) Thiazolo-rifamycin derivatives
JPS5382771A (en) Methoxybenzamide derivative
IL52270A0 (en) Hydrazinopyridazine derivatives
GB1524481A (en) Tetrahydo - imidazopyridine derivatives
JPS5398973A (en) Isoquinolineacetoamide derivative
GB1545021A (en) 5-norbicyclomycin derivatives
JPS52100431A (en) Anilinoacetate derivatives
JPS5283495A (en) Thienothiazine derivatives
GB1535080A (en) Naphthacenequinone derivatives